Jason Wittes
Stock Analyst at Roth Capital
(2.76)
# 1,802
Out of 5,139 analysts
60
Total ratings
50.94%
Success rate
5.76%
Average return
Main Sectors:
Stocks Rated by Jason Wittes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SPRY ARS Pharmaceuticals | Initiates: Buy | $40 | $10.63 | +276.29% | 1 | Sep 4, 2025 | |
| SYK Stryker | Maintains: Buy | $405 → $456 | $363.78 | +25.35% | 11 | May 2, 2025 | |
| ALUR Allurion Technologies | Reiterates: Buy | $16 | $1.85 | +764.86% | 2 | Mar 21, 2025 | |
| FBIO Fortress Biotech | Reiterates: Buy | $15 → $16 | $3.72 | +330.11% | 3 | Mar 11, 2025 | |
| OFIX Orthofix Medical | Reiterates: Buy | $22 | $14.08 | +56.25% | 5 | Feb 26, 2025 | |
| IRMD IRADIMED CORPORATION | Reiterates: Buy | $60 → $72 | $102.00 | -29.41% | 3 | Feb 14, 2025 | |
| TLSI TriSalus Life Sciences | Reiterates: Buy | $11 | $5.53 | +99.10% | 2 | Jan 24, 2025 | |
| GMED Globus Medical | Maintains: Buy | $100 → $115 | $93.47 | +23.03% | 4 | Dec 17, 2024 | |
| DERM Journey Medical | Reinstates: Buy | $11 | $8.01 | +37.33% | 1 | Jun 28, 2024 | |
| CRDL Cardiol Therapeutics | Initiates: Buy | $10 | $1.06 | +843.40% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $100 | $88.24 | +13.33% | 1 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.68 | +86.57% | 4 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $0.84 | +973.60% | 2 | Feb 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $23.97 | +212.89% | 2 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $17.74 | +24.01% | 3 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $120 | $87.31 | +37.44% | 7 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $206 | $142.06 | +45.01% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $145 | $214.62 | -32.44% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $23.18 | -35.29% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $200 | $13.64 | +1,366.28% | 3 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $30.57 | -14.95% | 1 | Feb 22, 2017 |
ARS Pharmaceuticals
Sep 4, 2025
Initiates: Buy
Price Target: $40
Current: $10.63
Upside: +276.29%
Stryker
May 2, 2025
Maintains: Buy
Price Target: $405 → $456
Current: $363.78
Upside: +25.35%
Allurion Technologies
Mar 21, 2025
Reiterates: Buy
Price Target: $16
Current: $1.85
Upside: +764.86%
Fortress Biotech
Mar 11, 2025
Reiterates: Buy
Price Target: $15 → $16
Current: $3.72
Upside: +330.11%
Orthofix Medical
Feb 26, 2025
Reiterates: Buy
Price Target: $22
Current: $14.08
Upside: +56.25%
IRADIMED CORPORATION
Feb 14, 2025
Reiterates: Buy
Price Target: $60 → $72
Current: $102.00
Upside: -29.41%
TriSalus Life Sciences
Jan 24, 2025
Reiterates: Buy
Price Target: $11
Current: $5.53
Upside: +99.10%
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100 → $115
Current: $93.47
Upside: +23.03%
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $8.01
Upside: +37.33%
Cardiol Therapeutics
Jun 26, 2024
Initiates: Buy
Price Target: $10
Current: $1.06
Upside: +843.40%
May 31, 2024
Reinstates: Buy
Price Target: $100
Current: $88.24
Upside: +13.33%
Mar 5, 2024
Reiterates: Buy
Price Target: $5
Current: $2.68
Upside: +86.57%
Feb 13, 2024
Initiates: Buy
Price Target: $9
Current: $0.84
Upside: +973.60%
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $23.97
Upside: +212.89%
Oct 20, 2023
Initiates: Buy
Price Target: $22
Current: $17.74
Upside: +24.01%
Oct 20, 2023
Initiates: Neutral
Price Target: $120
Current: $87.31
Upside: +37.44%
Sep 14, 2022
Initiates: Buy
Price Target: $206
Current: $142.06
Upside: +45.01%
Jun 27, 2022
Reinstates: Buy
Price Target: $145
Current: $214.62
Upside: -32.44%
Mar 3, 2022
Initiates: Buy
Price Target: $15
Current: $23.18
Upside: -35.29%
Feb 8, 2022
Initiates: Buy
Price Target: $200
Current: $13.64
Upside: +1,366.28%
Feb 22, 2017
Initiates: Buy
Price Target: $26
Current: $30.57
Upside: -14.95%